Aiju Tian

413 total citations
17 papers, 293 citations indexed

About

Aiju Tian is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Aiju Tian has authored 17 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Aiju Tian's work include Cardiac Fibrosis and Remodeling (6 papers), Cardiac Arrhythmias and Treatments (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). Aiju Tian is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), Cardiac Arrhythmias and Treatments (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). Aiju Tian collaborates with scholars based in China, Romania and United States. Aiju Tian's co-authors include Chengzhi Yang, Zijian Li, Zijian Li, Jimin Wu, Yuhui Qiao, Youyi Zhang, Rui Xing, Haiyan Lu, Xiaohui Zheng and Yunqi Jiang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Cell Death and Differentiation.

In The Last Decade

Aiju Tian

15 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiju Tian China 10 112 80 50 49 38 17 293
Caixia Lin China 12 171 1.5× 45 0.6× 38 0.8× 88 1.8× 20 0.5× 17 473
Ana Maluenda Australia 5 84 0.8× 38 0.5× 27 0.5× 20 0.4× 14 0.4× 8 291
Xiaowei Xing China 8 164 1.5× 63 0.8× 29 0.6× 14 0.3× 23 0.6× 13 331
Shrinidh Joshi United States 8 109 1.0× 67 0.8× 70 1.4× 12 0.2× 23 0.6× 17 385
Michelle Kuznicki United States 8 81 0.7× 38 0.5× 38 0.8× 38 0.8× 9 0.2× 22 321
Ningbo Pang China 8 142 1.3× 24 0.3× 68 1.4× 32 0.7× 25 0.7× 13 357
Daiki Funamoto Japan 8 144 1.3× 56 0.7× 70 1.4× 38 0.8× 8 0.2× 14 340
Maria do Céu Monteiro Portugal 9 118 1.1× 65 0.8× 31 0.6× 11 0.2× 15 0.4× 27 356
Cuiyu Bao China 10 123 1.1× 60 0.8× 96 1.9× 21 0.4× 10 0.3× 10 398
Jian Bi China 14 199 1.8× 144 1.8× 20 0.4× 31 0.6× 8 0.2× 26 505

Countries citing papers authored by Aiju Tian

Since Specialization
Citations

This map shows the geographic impact of Aiju Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiju Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiju Tian more than expected).

Fields of papers citing papers by Aiju Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiju Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiju Tian. The network helps show where Aiju Tian may publish in the future.

Co-authorship network of co-authors of Aiju Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Aiju Tian. A scholar is included among the top collaborators of Aiju Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiju Tian. Aiju Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tian, Aiju, Shubin Qiao, Jiansong Yuan, et al.. (2025). Comparison of Percutaneous Endocardial Septal Radiofrequency Ablation With Alcohol Septal Ablation in Treating Hypertrophic Obstructive Cardiomyopathy. Canadian Journal of Cardiology. 41(8). 1457–1465. 1 indexed citations
2.
Tian, Aiju, Yun‐Jiu Cheng, Xuhua Chen, et al.. (2025). Percutaneous endocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy. BMC Cardiovascular Disorders. 25(1). 564–564.
4.
Tian, Aiju, Jun Liu, Xiaogang Guo, et al.. (2024). Percutaneous endocardial septal radiofrequency ablation on syncope in patients with hypertrophic obstructive cardiomyopathy: a short-term safety and efficacy study. Annals of Medicine and Surgery. 86(7). 3880–3886. 3 indexed citations
5.
Jiang, Yunqi, Yuhui Qiao, Dan He, Aiju Tian, & Zijian Li. (2023). Adaptor protein HIP-55-mediated signalosome protects against ferroptosis in myocardial infarction. Cell Death and Differentiation. 30(3). 825–838. 28 indexed citations
6.
Tian, Aiju, Chengzhi Yang, & Zening Jin. (2020). Osteocalcin in acute stress response: from the perspective of cardiac diseases. Current Medical Research and Opinion. 36(4). 545–546.
7.
Yang, Chengzhi, Aiju Tian, Jimin Wu, et al.. (2019). Gold Nanoparticles for Targeting the Fibrotic Heart: A Probe Indicating Vascular Permeability. Journal of Nanoscience and Nanotechnology. 19(12). 7546–7550. 5 indexed citations
8.
Tian, Aiju, Chengzhi Yang, Wenjing Wang, et al.. (2018). Polyethylene-glycol-coated gold nanoparticles improve cardiac function after myocardial infarction in mice. Canadian Journal of Physiology and Pharmacology. 96(12). 1318–1327. 27 indexed citations
9.
Qiao, Yuhui, et al.. (2017). PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy. International Journal of Nanomedicine. Volume 12. 4709–4719. 18 indexed citations
10.
Yang, Chengzhi, Aiju Tian, & Zijian Li. (2016). Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice. Scientific Reports. 6(1). 20203–20203. 38 indexed citations
11.
He, Kangmin, Rui Xing, Xiaohua Yan, et al.. (2015). Mammalian actin‐binding protein 1/HIP‐55 is essential for the scission of clathrin‐coated pits by regulating dynamin‐actin interaction. The FASEB Journal. 29(6). 2495–2503. 7 indexed citations
12.
Yin, Qian, Haiyan Lu, Yajun Bai, et al.. (2015). A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway. British Journal of Pharmacology. 172(23). 5573–5585. 54 indexed citations
13.
Yang, Chengzhi, Zenggang Li, Zenggang Li, et al.. (2014). Regulation of cell survival by the HIP-55 signaling network. Molecular BioSystems. 10(6). 1393–1399. 10 indexed citations
14.
Liu, Ning, Rui Xing, Chengzhi Yang, et al.. (2014). HIP-55/DBNL-dependent regulation of adrenergic receptor mediates the ERK1/2 proliferative pathway. Molecular BioSystems. 10(7). 1932–1939. 15 indexed citations
15.
Lu, Haiyan, Aiju Tian, Jimin Wu, et al.. (2014). Danshensu Inhibits β-Adrenergic Receptors-Mediated Cardiac Fibrosis by ROS/p38 MAPK Axis. Biological and Pharmaceutical Bulletin. 37(6). 961–967. 52 indexed citations
16.
Tian, Aiju, et al.. (2014). [Establishment of a FVB/N mouse model of cardiac hypertrophy by isoprenaline].. PubMed. 46(6). 906–10. 1 indexed citations
17.
Yang, Chengzhi, Hui Yang, Jimin Wu, et al.. (2013). No overt structural or functional changes associated with PEG-coated gold nanoparticles accumulation with acute exposure in the mouse heart. Toxicology Letters. 222(2). 197–203. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026